JenaValve  ||| S:0 E:10 ||| JJ
The  ||| S:10 E:14 ||| DT
JenaValve  ||| S:14 E:24 ||| NN
is  ||| S:24 E:27 ||| VBZ
a  ||| S:27 E:29 ||| DT
next-generation  ||| S:29 E:45 ||| JJ
TAVI  ||| S:45 E:50 ||| NNP
device  ||| S:50 E:57 ||| NN
which  ||| S:57 E:63 ||| WDT
consists  ||| S:63 E:72 ||| VBZ
of  ||| S:72 E:75 ||| IN
a  ||| S:75 E:77 ||| DT
well-proven  ||| S:77 E:89 ||| JJ
porcine  ||| S:89 E:97 ||| NNS
root  ||| S:97 E:102 ||| VBP
valve  ||| S:102 E:108 ||| VBN
mounted  ||| S:108 E:116 ||| VBN
on  ||| S:116 E:119 ||| IN
a  ||| S:119 E:121 ||| DT
low-profile  ||| S:121 E:133 ||| JJ
nitinol  ||| S:133 E:141 ||| JJ
stent ||| S:141 E:146 ||| NN
.  ||| S:146 E:148 ||| .
Feeler  ||| S:148 E:155 ||| JJ
guided  ||| S:155 E:162 ||| JJ
positioning  ||| S:162 E:174 ||| NN
and  ||| S:174 E:178 ||| CC
clip  ||| S:178 E:183 ||| JJ
fixation  ||| S:183 E:192 ||| NN
on  ||| S:192 E:195 ||| IN
the  ||| S:195 E:199 ||| DT
diseased  ||| S:199 E:208 ||| JJ
leaflets  ||| S:208 E:217 ||| NNS
allow  ||| S:217 E:223 ||| VBP
for  ||| S:223 E:227 ||| IN
anatomically  ||| S:227 E:240 ||| JJ
correct  ||| S:240 E:248 ||| JJ
implantation  ||| S:248 E:261 ||| NN
of  ||| S:261 E:264 ||| IN
the  ||| S:264 E:268 ||| DT
device  ||| S:268 E:275 ||| NN
without  ||| S:275 E:283 ||| IN
rapid  ||| S:283 E:289 ||| JJ
pacing ||| S:289 E:295 ||| NN
.  ||| S:295 E:297 ||| .
Safety  ||| S:297 E:304 ||| NNP
and  ||| S:304 E:308 ||| CC
efficacy  ||| S:308 E:317 ||| NN
of  ||| S:317 E:320 ||| IN
transapical  ||| S:320 E:332 ||| JJ
aortic  ||| S:332 E:339 ||| JJ
valve  ||| S:339 E:345 ||| NNS
implantation  ||| S:345 E:358 ||| VBP
using  ||| S:358 E:364 ||| VBG
the  ||| S:364 E:368 ||| DT
JenaValve  ||| S:368 E:378 ||| NN
were  ||| S:378 E:383 ||| VBD
evaluated  ||| S:383 E:393 ||| VBN
in  ||| S:393 E:396 ||| IN
a  ||| S:396 E:398 ||| DT
multicentre  ||| S:398 E:410 ||| JJ
prospective  ||| S:410 E:422 ||| JJ
study  ||| S:422 E:428 ||| NN
that  ||| S:428 E:433 ||| WDT
showed  ||| S:433 E:440 ||| VBD
good  ||| S:440 E:445 ||| JJ
short  ||| S:445 E:451 ||| JJ
and  ||| S:451 E:455 ||| CC
midterm  ||| S:455 E:463 ||| JJ
results ||| S:463 E:470 ||| NNS
.  ||| S:470 E:472 ||| .
The  ||| S:472 E:476 ||| DT
valve  ||| S:476 E:482 ||| NN
was  ||| S:482 E:486 ||| VBD
CE-mark  ||| S:486 E:494 ||| JJ
released  ||| S:494 E:503 ||| VBN
in  ||| S:503 E:506 ||| IN
Europe  ||| S:506 E:513 ||| NNP
in  ||| S:513 E:516 ||| IN
September  ||| S:516 E:526 ||| NNP
2011 ||| S:526 E:530 ||| CD
.  ||| S:530 E:532 ||| .
A  ||| S:532 E:534 ||| DT
post-market  ||| S:534 E:546 ||| JJ
registry  ||| S:546 E:555 ||| NN
ensures  ||| S:555 E:563 ||| VBZ
on-going  ||| S:563 E:572 ||| JJ
and  ||| S:572 E:576 ||| CC
prospective  ||| S:576 E:588 ||| JJ
data  ||| S:588 E:593 ||| NN
collection  ||| S:593 E:604 ||| NN
in  ||| S:604 E:607 ||| IN
real-world  ||| S:607 E:618 ||| JJ
patients ||| S:618 E:626 ||| NNS
.  ||| S:626 E:628 ||| .
The  ||| S:628 E:632 ||| DT
transfemoral  ||| S:632 E:645 ||| JJ
JenaValve  ||| S:645 E:655 ||| JJ
delivery  ||| S:655 E:664 ||| NN
system  ||| S:664 E:671 ||| NN
will  ||| S:671 E:676 ||| MD
be  ||| S:676 E:679 ||| VB
evaluated  ||| S:679 E:689 ||| VBN
in  ||| S:689 E:692 ||| IN
a  ||| S:692 E:694 ||| DT
first-in-man  ||| S:694 E:707 ||| JJ
study  ||| S:707 E:713 ||| NN
in  ||| S:713 E:716 ||| IN
the  ||| S:716 E:720 ||| DT
near  ||| S:720 E:725 ||| JJ
future ||| S:725 E:731 ||| NN
.  ||| S:731 E:733 ||| .
